Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(30 sites)
United States
Chinle Center for Indigenous Health, Chinle, Arizona Avacare (CCT Research), Phoenix, Arizona Whiteriver Center for Indigenous Health, Whiteriver, Arizona Chase Medical Research, Waterbury, Connecticut CenExel (RCA), Hollywood, Florida Eximia (Health Awareness), Jupiter, Florida Eximia (Health Awareness), Port Saint Lucie, Florida Precision Clinical Research, Sunrise, Florida The Villages, The Villages, Florida DelRicht Clinical Research, Stockbridge, Georgia Velocity Clinical Valparaiso, Valparaiso, Indiana Johnson County Clin-Trials, LLC, Lenexa, Kansas DelRicht Clinical Research, New Orleans, Louisiana Velocity (Meridian Clinical Research), Rockville, Maryland DM Clinical Research-Detroit, Southfield, Michigan AMR, Kansas City, Missouri DelRicht Research (Command Family Medicine), Springfield, Missouri Quality Clinical Research, Omaha, Nebraska Center of American Indian Health, Gallup, New Mexico Shiprock Center for Indigenous Health, Shiprock, New Mexico Rochester Clinical Research, Inc., Rochester, New York Headlands (Trial Management Associates), Wilmington, North Carolina Tekton Research, Edmond, Oklahoma DelRicht Research, Hendersonville, Tennessee Tekton Research, Austin, Texas REX Clinical Trials, Beaumont, Texas Flourish Research, San Antonio, Texas DM Clinical Research, Sugar Land, Texas Alcanza (Charlottesville Medical Research), Charlottesville, Virginia Health Research of Hampton Roads, Inc., Newport News, Virginia